0001709409-23-000007.txt : 20230629 0001709409-23-000007.hdr.sgml : 20230629 20230629172031 ACCESSION NUMBER: 0001709409-23-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20230629 DATE AS OF CHANGE: 20230629 EFFECTIVENESS DATE: 20230629 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Calidi Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001758478 IRS NUMBER: 471437012 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-485625 FILM NUMBER: 231058516 BUSINESS ADDRESS: STREET 1: 11011 N TORREY PINES ROAD STREET 2: STE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-794-9600 MAIL ADDRESS: STREET 1: 11011 N TORREY PINES ROAD STREET 2: STE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0001758478 Calidi Biotherapeutics, Inc. 4475 Executive Drive, Suite 200 San Diego CA CALIFORNIA 92121 858-794-9600 NEVADA Stemimmune, Inc. None Corporation true Allan Camaisa 4475 Executive Drive, Suite 200 San Diego CA CALIFORNIA 92121 Executive Officer Director Tony Kalajian 4475 Executive Drive, Suite 200 San Diego CA CALIFORNIA 92121 Executive Officer Interim Chief Financial Officer Boris Minev 4475 Executive Drive, Suite 200 San Diego CA CALIFORNIA 92121 Executive Officer Interim Chief Medical Officer Stephen Thesing 4475 Executive Drive, Suite 200 San Diego CA CALIFORNIA 92121 Executive Officer Chief Business Officer George Ng 4475 Executive Drive, Suite 200 San Diego CA CALIFORNIA 92121 Director Wendy Pizarro 4475 Executive Drive, Suite 200 San Diego CA CALIFORNIA 92121 Executive Officer Chief Administrative Officer, Chief Legal Officer, Chief Diversity Officer Anthony F. Santidrian 4475 Executive Drive, Suite 200 San Diego CA CALIFORNIA 92121 Executive Officer Senior Vice President, Global Head of Research and Development Alfonso Zulueta 4475 Executive Drive, Suite 200 San Diego CA CALIFORNIA 92121 Director David Sans 4475 Executive Drive, Suite 200 San Diego CA CALIFORNIA 92121 Executive Officer Chief of Corporate Development Amish Patel 4475 Executive Drive, Suite 200 San Diego CA CALIFORNIA 92121 Executive Officer Vice President of Technical Operations Heehyoung Lee 4475 Executive Drive, Suite 200 San Diego CA CALIFORNIA 92121 Director Scott Leftwich 4475 Executive Drive, Suite 200 San Diego CA CALIFORNIA 92121 Director James Schoeneck 4475 Executive Drive, Suite 200 San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06c false 2023-06-20 false true true true Series B Preferred Stock and Common Stock false 0 Arcadia Securities, LLC 44656 Brookline Capital Markets None 1370 Avenue of the Americas 29th Floor New York NY NEW YORK 10019 CA CALIFORNIA GA GEORGIA NY NEW YORK false 25000000 4999975 20000025 Series B Preferred Stock and Common Stock issuable conversion of Series B Preferred Stock false 1 50000 true 0 Reflects 1% of sold amount, commission ranges from 1%-5% 648000 true Estimated payment for 3 months of payroll and related costs false Calidi Biotherapeutics, Inc. /s/ Allan Camaisa Allan Camaisa CEO 2023-06-28